PubMed=19325077; DOI=10.1126/science.1172482
Yu J.-Y., Hu K.-J., Smuga-Otto K., Tian S.-L., Stewart R., Slukvin I.I., Thomson J.A.
Human induced pluripotent stem cells free of vector and transgene sequences.
Science 324:797-801(2009)

PubMed=21296996; DOI=10.1182/blood-2010-07-298331
Hu K.-J., Yu J.-Y., Suknuntha K., Tian S.-L., Montgomery K., Choi K.-D., Stewart R., Thomson J.A., Slukvin I.I.
Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells.
Blood 117:E109-E119(2011)

PubMed=21983960; DOI=10.1038/nmeth.1699
Phanstiel D.H., Brumbaugh J., Wenger C.D., Tian S.-L., Probasco M.D., Bailey D.J., Swaney D.L., Tervo M.A., Bolin J.M., Ruotti V., Stewart R., Thomson J.A., Coon J.J.
Proteomic and phosphoproteomic comparison of human ES and iPS cells.
Nat. Methods 8:821-827(2011)

PubMed=26670276; DOI=10.1038/mtna.2015.42
Kang H., Minder P., Park M.A., Mesquitta W.-T., Torbett B.E., Slukvin I.I.
CCR5 disruption in induced pluripotent stem cells using CRISPR/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus.
Mol. Ther. Nucleic Acids 4:e268.1-e268.10(2015)

PubMed=27293150; DOI=10.1016/j.stemcr.2016.05.006
Salomonis N., Dexheimer P.J., Omberg L., Schroll R., Bush S., Huo J., Schriml L.M., Sui S.H., Keddache M., Mayhew C.N., Shanmukhappa S.K., Wells J.M., Daily K., Hubler S., Wang Y.-L., Zambidis E.T., Margolin A.A., Hide W.A., Hatzopoulos A.K., Malik P., Cancelas J.A., Aronow B.J., Lutzko C.
Integrated genomic analysis of diverse induced pluripotent stem cells from the Progenitor Cell Biology Consortium.
Stem Cell Reports 7:110-125(2016)